Scott Chesla
Georgia Institute of Technology
12 Papers
252 Citations
Scott Chesla is an academic researcher from Georgia Institute of Technology. The author has contributed to research in topics: Receptor–ligand kinetics & Receptor. The author has an hindex of 8, co-authored 12 publications. Previous affiliations of Scott Chesla include Pratt & Whitney.
Chat about Author
Papers
Ligand binding and phagocytosis by CD16 (Fc gamma receptor III) isoforms. Phagocytic signaling by associated zeta and gamma subunits in Chinese hamster ovary cells.
TL;DR: The results demonstrate that glycosylphosphatidylinositol-anchored CD16B alleles differ from CD16A in their ability to mediate phagocytosis.
119
Patent
Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs
Alvin E. Peterson,Lee K. Landeen,John Bennett,Jason Gee,Scott Chesla,Joan Zeltinger,James H. Flatt,Mark A. Applegate,Noushin Dunkelman,Stephen V. Kemmerrer +9 more
- 30 Dec 1998
TL;DR: An apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing three-dimensional tissue constructs is described in this article, which includes a fluid reservoir (18), a pump (30), at least one treatment chamber (10), and a means for controlling media flow characteristics around a tissue construct disposed within the treatment chamber.
110
Measuring receptor/ligand interaction at the single-bond level: experimental and interpretative issues.
TL;DR: It is concluded that no single criterion is sufficient to ensure that single bonds are actually observed, and a cumulative body of evidence may provide reasonable confidence.
101
The Membrane Anchor Influences Ligand Binding Two-dimensional Kinetic Rates and Three-dimensional Affinity of FcγRIII (CD16)
TL;DR: Data demonstrate that a covalent modification of an Ig superfamily receptor at the carboxyl terminus of the ectodomain can have an impact on ligand bindingKinetic rates and affinity are measured and it is shown that the anchor influenced kinetic rates.
77
Patent
Apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing tissue, synthetic, or mechanical heart valves orvalve segments
Alvin E. Peterson,Lee K. Landeen,John Bennett,Jason Gee,Scott Chesla,Joan Zeltinger +5 more
- 07 Jun 1995
TL;DR: In this article, an apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing heart valves is described, which can be used to produce viable human cells.
32